Sarcoidosis is a chronic systemic inflammatory disease of unknown aetiology characterized by non-caseating epithelioid granulomas. Although it most commonly presents with hilar lymphadenopathy or pulmonary infiltration, clinically overt cardiac involvement occurs in approximately 5% of cases and is associated with an...
S. Montuoro, E. Monda, E. Bobbio et al.· European Heart Journal· 0 citations
Myocardial fibrosis is a major pathological component of cardiac remodelling and contributes to ventricular stiffness, impaired myocardial function, heart failure progression, and arrhythmic vulnerability across a broad spectrum of cardiomyopathies. In hypertrophic cardiomyopathy (HCM), fibrotic remodelling encompasses...
I. Fortuna, Janete Santos, P. Soeiro et al.· International Journal of Mol...· 0 citations
While BB and RASi are commonly used in ES-HCM, MRA and SGLT2i are prescribed less frequently and in patients with a worse clinical profile, suggesting both clinical inertia and limitations inherent to the disease pathophysiology.
G. Tini, Isabella Perlati, S. Palma et al.· International Journal of Car...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.